EPIDAUROS Biotechnologie AG

EPIDAUROS is a leading global provider of clinical genotyping services with a portfolio of more than 1500 validated pharmacogenetic assays. As a partner of the pharmaceutical industry, our clients know they can rely on us to expedite the development of safer and more effective drugs. Our services are based on competence gained from many years of pioneering research in the field of pharmacogenetics. We apply the highest quality standards and deliver results that meet regulatory submission standards worldwide

Contact Details: Am Neuland 1 Bernried Germany Tel: 49 (0) 8158 - 99 85-0 Fax: 49 (0) 8158 - 99 85-48 Email: hr@biolex.com WWW: www.epidauros.com/

Recent Publications by EPIDAUROS Biotechnologie AG:
Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11). Biliary excretion of bile salts and other bile constituents from...	9th December, 2006	EPIDAUROS Biotechnologie AG, Bernried, Germany.	Drug Metab Dispos. 2006 Sep;34(9):1582-99. Epub 2006 Jun 8. DOI Direct Link
EPIDAUROS Biotechnologie AG. EPIDAUROS Biotechnologie AG is a leading provider of pharmacogenetic...	30th June, 2006	EPIDAUROS Biotechnologie AG, Am Neuland 1,82347 Bernried, Germany.	Pharmacogenomics. 2005 Jul;6(5):535-8. DOI Direct Link
Pharmacogenomics and Clinical R&D. Biliary excretion of bile salts and other bile constituents from...	16th June, 2006	EPIDAUROS Biotechnologie AG, Am Neuland 1, 82347 Bernried, Germany.	Pharmacogenomics. 2005 Dec;6(8):801-6. DOI Direct Link
Pharmacogenetics: development issues and solutions for safe and effective medicines. Biliary excretion of bile salts and other bile constituents from...	28th April, 2006	EPIDAUROS Biotechnologie AG, Am Neuland 1, 82347 Bernried, Germany.	Pharmacogenomics. 2006 Mar;7(2):149-55. DOI Direct Link
Three haplotypes associated with CYP2A6 phenotypes in Caucasians. The human cytochrome P450 2A6 (CYP2A6) enzyme metabolizes several...	19th October, 2005	EPIDAUROS Biotechnologie AG, Bernried, Germany.	Pharmacogenet Genomics. 2005 Sep;15(9):609-24.
→View more EPIDAUROS Biotechnologie AG research publications.

BioNews Results for EPIDAUROS Biotechnologie AG:
EU patent for Clinical Data's gene MDR1	PharmaBiz:  Jul 1 2008 6:05AM Matching: epidauros biotechnologie ag
Clinical Data Secures EU Patent for MDR1 - A Key Multi-Drug Resistance Gene	Stockwatch:  Jun 26 2008 10:51AM Matching: epidauros biotechnologie ag
Clinical Data Reports Strong Fourth Quarter and Fiscal Year 2008 Results	Pharma Live:  Jun 16 2008 11:29AM Matching: epidauros biotechnologie ag
Cogenics, Roche's 454 Life Sciences and Limagrain to Jointly Develop Solutions for Crop SNP Discovery With Nex	Stockwatch:  Jun 3 2008 10:41AM Matching: epidauros biotechnologie ag

EPIDAUROS Biotechnologie AG Patents:
US Patent No.	Title
6723508	Method for determining the presence of at least one allele of a GSTT1 deletion mutant
6645745	Identification of a new member of the cytochrome P450 3A (CYP3A) gene family: CYP3AX

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 164 times since April 2007, the link to the organisation's website has been followed 29 times

Recent Search Terms used to find this page: www.epidauros | epidauros.com | Epidauros Biotechnology Bernried Germany | Epidauros Biotechnology Bernried Germany | .

Search for more companies in Bernried

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for EPIDAUROS Biotechnologie AG